EQT Infrastructure VI, through its indirectly owned subsidiary Otello BidCo AB, announces a recommended public offer to the shareholders of OX2 AB (publ) (“OX2”). The shares are admitted to trading on Nasdaq Stockholm, Large Cap.

OX2, founded in 2004, is a leading renewable energy platform with a large and diverse project portfolio across all major renewable energy technologies (onshore and offshore wind, solar, and storage) and is today one of the largest developers of onshore wind in Europe.

The total value of the offer is approximately SEK 16.4 billion.

Vinge’s team mainly consists of Sofie Bjärtun, Erik Sjöman, Linnéa Sellström, Joel Magnusson, Lorin Arabi and Maximilian Bengtsson (apital Markets and Public M&A), Christoffer Thalin, Peter Sundgren, Filip Öhrner, Daniel Daun, Niklas Törnell and Jonatan Karlsson (Energy, M&A), Sebastian Örndahl, Hampus Peterson, Lovisa Lewin and Ebba Ehrling Sjögren (Regulatory), Kamyar Najmi (Banking and finance), Lina Österberg, Tilda Hall and Agnes Pigg (Environment and Real Estate) Sam Seddigh and Alice Göransson (Employment), Fredrika Hjelmberg and Ian Linde (IT/GDPR), Gulestan Ali (Compliance) and Julia Ulander Kull (Transaction Support Coordinator).

 

Related

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026

Vinge advises Axcel in connection with the investment in Sanviva

Vinge has advised the Nordic private equity firm Axcel in connection with the establishment of Sanviva, a new European medical device distribution network.
June 03, 2026